I agree that R/S is bad for the stock price but there are a few stocks that made it through okay; Citi Group and Bank of America. They pulled through because of their underlining assets. NBRV have drugs selling in the open markets with others in the pipeline. The reason for the R/S is get their share price above listing rules. With the action lately and positive news, I would vote no on the R/S and let the price unleash upward. As others said, the lingering R/S pending is casting an overcast on the share price. Let’s see what next week brings us.
News 
Market Data 
Discover 
